Abbvie (($ABBV)), Genmab (Otc) (($GMAB)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study.
https://www.tipranks.com/news/company-announcements/abbvie-and-genmabs-promising-update-on-b-cell-lymphoma-treatment-study
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.